Hyperopia News and Research

RSS

Hyperopia is also known as far-sightedness and it is an ophthalmological condition, a disorder of refraction, which presents as blurring of near vision, but clear far vision. Hyperopic individuals typically have problems with tasks that require near vision, such as reading a book or threading a needle.

Study finds high rate of anisometropia in older adults

Follow-up in older adults shows a high rate of anisometropia, or differing levels of visual abnormalities between eyes, reports a study in Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

21 Nov 2013

Avedro initiates US clinical trials for Lasik with cross-linking and pulsed accelerated cross-linking

Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking.

12 Nov 2013

Portable screening devices allow pediatricians to screen children for vision problems

Portable screening devices allow pediatricians to successfully screen children for vision problems, including amblyopia, according to an abstract presented Oct. 25 at the American Academy of Pediatrics (AAP) National Conference and Exhibition in Orlando.

25 Oct 2013

Government investment in eye examinations may boost the economy

Governments could add thousands of millions of dollars to the global economy simply by investing in eye examinations and the provision of glasses for some 703 million people who need them, according to a study published this month in the Bulletin of the World Health Organization.

6 Oct 2012

Loma Linda University's Vision Intervention Program receives Spot screener from PediaVision

PediaVision today announced that Loma Linda University's Vision Intervention Program is the first in the State of California to receive the revolutionary new vision screener from PediaVision called "Spot."

30 Sep 2011

$Avedro completes two Phase III corneal cross-linking studies in keratoconus, ectasia post-refractive surgery$

Avedro completes two Phase III corneal cross-linking studies in keratoconus, ectasia post-refractive surgery

Avedro, Inc. today announced the completion of all one-year follow-up visits for patients enrolled in its two multi-center Phase III studies evaluating the safety and efficacy of corneal collagen cross-linking for the treatment of progressive keratoconus and ectasia following refractive surgery.

18 May 2011

Scientists discover new gene underlying angle-closure glaucoma

Jackson Laboratory researchers and their collaborators have reported their discovery of a gene implicated in an acute and severe form of glaucoma known as angle-closure glaucoma.

3 May 2011

Carl Zeiss Meditec’s MEL 80 Excimer Laser receives PMA from FDA to treat hyperopia

Carl Zeiss Meditec, Inc. announced today that the MEL 80 Excimer Laser has received premarket approval from the U.S. Food and Drug Administration for the treatment of hyperopia.

29 Mar 2011

STAAR Surgical exceeds 200,000 Visian ICL global implants

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that the worldwide total number of Visian® ICL implants in patients has exceeded 200,000. Since 1994, STAAR's Implantable Collamer® Lenses (ICLs) have been used in refractive eye surgery as an alternative to LASIK. Manufactured with STAAR's proprietary Collamer material, Visian ICLs provide a safe and effective alternative in the permanent correction of myopia, hyperopia, and in the case of the Toric ICL, astigmatism.

4 Jan 2011

South Carolina optometrists provide eye, vision assessments for infants through InfantSEE

Due to the overwhelming number of children with eye and vision problems across the United States, South Carolina optometrists are devoting appointments to no-cost, comprehensive eye and vision assessments for infants between six to 12 months of age through InfantSEE.

21 Sep 2010

STAAR Surgical's Visian Implantable Collamer Lens featured prominently at 2010 ESCRS Congress

STAAR Surgical Company, the leading worldwide developer, manufacturer and marketer of phakic intraocular lenses, today announced that the Visian Implantable Collamer® Lens (ICL) was featured prominently in more than 40 presentations by leading ophthalmologists at meetings prior to and during the 2010 Congress of European Society of Cataract and Refractive Surgeons (ESCRS) held in Paris, France from September 4 through 8, 2010.

8 Sep 2010

STAAR Surgical second-quarter total net revenue increases 3.7% to $13.6 million

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today reported results for the second quarter ended July 2, 2010. Revenue for the period grew 3.7% to $13.6 million with the revenue from core products, IOLs and ICLs, increasing by 7%. For the first half of 2010 core product revenues increased by 11% reflecting market share gains by STAAR.

4 Aug 2010

STAAR Surgical receives CE Mark approval for product improvements to Visian Implantable Collamer Lens

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced CE Mark approval for a range of product improvements to the Company's Visian Implantable Collamer® Lens (ICL™) that more than doubles the current Visian addressable market in Europe.

20 May 2010

Promising new generation of contact lenses for myopia control

An international team of researchers tested a contact lens that may reduce the progress of nearsightedness, or myopia, by fully correcting the central vision but reducing the relative peripheral farsightedness, or hyperopia.

6 May 2010

$Innovative new contact lens to correct hyperopia without refractive surgery$

Innovative new contact lens to correct hyperopia without refractive surgery

Jaume Pauné, a graduate of the Master's Degree in Optometry and Vision Sciences at the UPC-Barcelona Tech's College of Optics and Optometry, has designed an innovative new contact lens that will improve the vision quality of thousands of people without surgery. The Spanish Association of Opticians and Optometrists has granted its National Award to Mr. Pauné for his innovative work in this field.

20 Apr 2010

Intermittent exotropia will lead to nearsightedness in most children

Intermittent exotropia, a condition in which the eyes turn outward while looking at an object, occurs in about 1% of American children and is less common than esotropia, where the eyes turn inward. In an article published in the March 2010 issue of the American Journal of Ophthalmology, researchers from the Mayo Clinic and Mayo Foundation, Rochester, MN, followed 135 patients with intermittent exotropia over a 20-year period and found that slightly more than 90% of these children became nearsighted by the time they reached their 20s.

8 Apr 2010

FGX International becomes wholly-owned subsidiary of Essilor

FGX International Holdings Limited announced that it has completed its merger with a subsidiary of Essilor International of Charenton-le-Pont, France.

15 Mar 2010

Essilor International completes acquisition of FGX International Holdings

Essilor International has acquired FGX International Holdings Limited, the North American market leader in the design and sale of non-prescription reading glasses. The transaction was completed following approval by FGX shareholders.

15 Mar 2010

Highlights of January 2010 'Ophthalmology'

This month's Ophthalmology, the journal of the American Academy of Ophthalmology, includes a research review of the effects of Vitamins C and E and magnesium on diabetic retinopathy and findings from the first large study of vision problems in Hispanic and African-American infants and young children.

5 Jan 2010

Essilor International to acquire FGX International Holdings

FGX International Holdings Limited today announced that it has signed a definitive agreement to merge with a subsidiary of Essilor International of Charenton-le-Pont, France. Essilor shares trade on the NYSE Euronext Paris market and are included in the CAC 40 index.

16 Dec 2009